Search research articles
Contact Us
Filters
Showing results (1-10 of 161) with videos related to
Page
of 17
Sort By:
Journal of the Neurological Sciences
|
March 10, 2007
MRI relapses have significant pathologic and clinical implications in multiple sclerosis
Anthony Traboulsee
Journal of Neurology
|
November 19, 2004
MRI: role in optimising treatment
Anthony Traboulsee
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
October 26, 2014
How useful are MS registries?
Anthony Traboulsee, Katrina McMullen
Neurology
|
August 14, 2019
Author response: Safety and efficacy of venoplasty in MS: A randomized, double-blind, sham-controlled phase II trial
Anthony Traboulsee, Lindsay Machan
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
September 21, 2018
Nothing Ventured, Nothing Gained? Navigating Disease-Modifying Treatment in Multiple Sclerosis
Jodie M Burton, Anthony Traboulsee
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
July 14, 2020
Short-term outcomes of pediatric multiple sclerosis patients treated with alemtuzumab at a Canadian University multiple sclerosis clinic
David Jure Hunt, Anthony Traboulsee
Archives of Neurology
|
October 12, 2011
Postvaccination Miller Fisher syndrome
Ashkan Shoamanesh, Kristine Chapman, Anthony Traboulsee
Neuroimaging Clinics of North America
|
June 28, 2024
Routine MR Imaging Protocol and Standardization in Central Nervous System Demyelinating Diseases
Anthony Traboulsee, David K B Li
Neuroimaging Clinics of North America
|
December 11, 2008
Conventional MR imaging
Anthony Traboulsee, David K B Li
Lancet (London, England)
|
June 5, 2003
Interferons in relapsing remitting multiple sclerosis
Don Paty, Barry Arnason, David Li, et al.
Page
of 17
Search research articles
Search
Showing results (1-10 of 161) with videos related to
Sort By:
Page
of 17
Journal of the Neurological Sciences
|
March 10, 2007
MRI relapses have significant pathologic and clinical implications in multiple sclerosis
Anthony Traboulsee
Journal of Neurology
|
November 19, 2004
MRI: role in optimising treatment
Anthony Traboulsee
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
October 26, 2014
How useful are MS registries?
Anthony Traboulsee, Katrina McMullen
Neurology
|
August 14, 2019
Author response: Safety and efficacy of venoplasty in MS: A randomized, double-blind, sham-controlled phase II trial
Anthony Traboulsee, Lindsay Machan
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
September 21, 2018
Nothing Ventured, Nothing Gained? Navigating Disease-Modifying Treatment in Multiple Sclerosis
Jodie M Burton, Anthony Traboulsee
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
July 14, 2020
Short-term outcomes of pediatric multiple sclerosis patients treated with alemtuzumab at a Canadian University multiple sclerosis clinic
David Jure Hunt, Anthony Traboulsee
Archives of Neurology
|
October 12, 2011
Postvaccination Miller Fisher syndrome
Ashkan Shoamanesh, Kristine Chapman, Anthony Traboulsee
Neuroimaging Clinics of North America
|
June 28, 2024
Routine MR Imaging Protocol and Standardization in Central Nervous System Demyelinating Diseases
Anthony Traboulsee, David K B Li
Neuroimaging Clinics of North America
|
December 11, 2008
Conventional MR imaging
Anthony Traboulsee, David K B Li
Lancet (London, England)
|
June 5, 2003
Interferons in relapsing remitting multiple sclerosis
Don Paty, Barry Arnason, David Li, et al.
Page
of 17